Know the Facts about Coronavirus Disease 2019 (COVID-19)

Read the Latest View Closings Visitor Restrictions

Condition | Cancer

ALLIANCE A081105

  • IRB Number: ALLIANCE A081105
  • Contact Name: Rachel O'Loughlin, RN BSN
  • Status: Enrolling
  • Phone: (585) 747-4555
  • Lead Researcher: Mehul Patel, MD

Description

Randomized Study of Erlotinib vs Observation In Patients with Completely Resected Epidermal Growth Factor Receptor (EGFR) Mutant Non-Small Cell Lung Cancer (NSCLC)

https://clinicaltrials.gov/ct2/show/NCT02193282

Related Clinical Trials

Chemo Brain

Objective Measurement of Cognitive Impairment in Breast Cancer Survivors who received Adjuvant Chemotherapy and Report Cognitive Decline
View Clinical Trial

Quality of Life

Quality of Life Assessment as a Predictor of Survival in Lung Cancer
View Clinical Trial

Post-Mastectomy Radiotherapy

Impact of Timing of Post-Mastectomy Radiation Therapy and Breast Reconstruction: Physician-Reported Complications, Aesthetic Results, and Patient-Reported Outcomes
View Clinical Trial
View All Clinical Trials